Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sandvik | SVKB | Jan 8, 2025 | 17.81 | +0.31 |
Sandvik ADR | SVK | Jan 8, 2025 | 17.50 | 0.00 |
Sangamo Therapeutics, Inc. | GBY | Jan 8, 2025 | 1.13 | -11.78 |
Sangoma Technologies Corporation | 54GA | Jan 8, 2025 | 6.65 | +3.10 |
Saniona | 30S | Jan 8, 2025 | 0.61 | -0.49 |
Sanken Electric Co. Ltd. | XSK | Jan 8, 2025 | 37.00 | +0.54 |
Sankyo Co | SOK | Jan 8, 2025 | 12.80 | -0.78 |
Sankyu Inc. | SNK | Jan 8, 2025 | 33.60 | +0.60 |
Sanlam | LA6A | Jan 8, 2025 | 4.56 | +2.70 |
Sanlam | LA6S | Jan 8, 2025 | 8.95 | +2.29 |
Sanlorenzo S.p.a. | 6SZA | Jan 8, 2025 | 32.45 | +0.15 |
Sanmina Corporation | SAYN | Jan 8, 2025 | 74.44 | +0.38 |
Sanofi | SNW | Jan 8, 2025 | 95.43 | -0.70 |
Sanofi - American Depositary Shares | SNW2 | Jan 8, 2025 | 47.20 | -0.84 |
Sanok Rubber Company SA | 1NX | Jan 8, 2025 | 4.96 | -3.31 |
Sanoma | SNQB | Jan 8, 2025 | 7.95 | -0.13 |
Sanrio Company Ltd. | SJ8 | Jan 8, 2025 | 32.00 | -3.61 |
Santacruz Silver Mining Ltd | 1SZ | Jan 8, 2025 | 0.20 | +7.72 |
Santander Bank Polska S. A. | BZI | Jan 8, 2025 | 110.25 | +1.85 |
Santen Pharmaceutical Co. Ltd. | SZD | Jan 8, 2025 | 9.60 | -0.52 |
Santorius AG Unsponsored ADR (Germany) | SRT4 | Jan 8, 2025 | 36.80 | +6.98 |
Santos Ltd | STS1 | Jan 8, 2025 | 4.15 | +0.44 |
Sanu Gold Corp | L73 | Jan 8, 2025 | 0.10 | 0.00 |
Sanwa Holdings Corp. | XST | Jan 8, 2025 | 26.20 | -0.76 |
SANY INTL | YXS | Jan 8, 2025 | 0.54 | -0.09 |
Sanyo Chemical Industries Ltd. | XSI | Jan 8, 2025 | 24.00 | 0.00 |
SAP SE ADS | SAPA | Jan 8, 2025 | 248.00 | +3.33 |
Sap SE | SAP | Jan 8, 2025 | 245.00 | +1.34 |
Sapiens International Corporation N.V. - | S3P | Jan 8, 2025 | 24.80 | +0.81 |
Sappi Ltd | SPIA | Jan 8, 2025 | 2.30 | -6.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.